Sanctuary Advisors LLC Makes New $3.81 Million Investment in HCA Healthcare, Inc. $HCA

Sanctuary Advisors LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,781 shares of the company’s stock, valued at approximately $3,814,000.

Several other institutional investors and hedge funds have also bought and sold shares of HCA. BlackRock Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $5,069,974,000. State Street Corp increased its position in HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after purchasing an additional 76,039 shares during the period. Capital World Investors lifted its position in shares of HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC increased its position in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares during the period. Finally, Norges Bank bought a new stake in HCA Healthcare during the 4th quarter valued at approximately $1,262,513,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $428.90 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The firm’s 50-day moving average is $398.59 and its 200 day moving average is $442.83. The stock has a market cap of $92.86 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $6.84 earnings per share. On average, equities analysts expect that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.45%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HCA shares. The Goldman Sachs Group lowered their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday, July 28th. Truist Financial lowered their price objective on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. UBS Group reduced their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Finally, Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a report on Tuesday, July 14th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.